ALK, ALK receptor tyrosine kinase, 238

N. diseases: 519; N. variants: 41
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.060 AlteredExpression phenotype BEFREE NPM-ALK-deregulated kinase activity drives several pathways that support malignant transformation of lymphoma cells. 26657151 2016
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.060 Biomarker phenotype BEFREE CHC-ALK is comparable to full-length CHC in both functions indicating that malignant transformation in cells expressing CHC-ALK is not because of any change in clathrin function. 21362119 2011
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.060 Biomarker phenotype BEFREE Aneuploidy without ALK abnormalities was associated with malignant transformation in three of five cases. 11406658 2001
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.060 Biomarker phenotype BEFREE Role of signal transducer and activator of transcription 5 in nucleophosmin/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells. 11522649 2001
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.060 Biomarker phenotype BEFREE The fusion protein had a molecular weight (250 kd) that differs from all known ALK products, and it was autophosphorylated in an in vitro kinase assay, confirming that it is constitutively active and hence capable of contributing to malignant transformation. 10807789 2000
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.060 AlteredExpression phenotype BEFREE Unscheduled expression of the truncated ALK may contribute to malignant transformation in these lymphomas. 8122112 1994